01 / 21

Anticoagulants
Monitoring & Bleeding Precautions

Master the labs, antidotes, and safety steps for heparin, warfarin, and DOACs on the NCLEX-RN.

NCLEX-RN

What Are Anticoagulants?

Anticoagulants are medications that slow the body's clotting process. They do not "thin" blood or dissolve existing clots — they prevent new clots from forming and stop existing clots from growing.

Three Drug Families

Heparin (IV/SubQ)
Fast-acting. Includes unfractionated heparin and LMWH (enoxaparin).
Warfarin (PO)
Slow onset. Affects vitamin K clotting factors. Needs frequent monitoring.
DOACs (PO)
Direct oral agents like apixaban, rivaroxaban, dabigatran. Minimal monitoring.

Why Monitoring Matters

Drug Effect (Clotting Time) Too Low: Clot Risk Therapeutic Window Too High: Bleeding Risk

The Core Lab Rule

H
Heparin uses aPTT. Therapeutic aPTT is \( 1.5 \) to \( 2.5 \times \) the control value.
W
Warfarin uses PT/INR. Therapeutic INR for most conditions is \( 2.0 \) to \( 3.0 \).
D
DOACs need no routine labs. Just monitor renal function and bleeding signs.

Know the Antidotes

Heparin
Antidote: Protamine sulfate. Reverses heparin and LMWH bleeding.
Warfarin
Antidote: Vitamin K (phytonadione). FFP for rapid reversal.
DOACs
Dabigatran: idarucizumab. Apixaban/rivaroxaban: andexanet alfa.

Heparin vs. Warfarin

Heparin Warfarin
RouteIV / SubQOral (PO)
OnsetImmediateSlow (\( 3 \)–\( 5 \) days)
LabaPTTPT / INR
AntidoteProtamine sulfateVitamin K
PregnancySafeContraindicated

Reading the INR

1.0 2.0 3.0 4.0+ < 2.0 Clot risk 2.0–3.0 Therapeutic > 3.0 Bleed risk Higher INR = more anticoagulated = more bleeding

Bleeding Precautions Checklist

1
Use a soft toothbrush and an electric razor to avoid cuts.
2
Apply pressure to injection or venipuncture sites for \( 5 \)–\( 10 \) minutes.
3
Avoid IM injections, aspirin, and NSAIDs unless ordered.
4
Watch for bleeding: blood in urine/stool, bruising, gums, nosebleeds.
5
Prevent falls and use fall precautions to avoid internal bleeding.

Nursing Action Steps

1
Check the lab before giving the dose (aPTT for heparin, INR for warfarin).
2
Compare to therapeutic range. If too high, hold the dose and notify the provider.
3
Assess for active bleeding before and during therapy.
4
Teach the patient bleeding precautions and consistent diet (for warfarin).

Warfarin & Vitamin K Diet

Vitamin K is the antidote to warfarin, so foods high in vitamin K reduce warfarin's effect. The teaching is not to avoid these foods — it is to keep intake consistent day to day.

Worked Example 1

Therapeutic aPTT is \( 1.5 \) to \( 2.5 \times \) control: \( 30 \times 1.5 = 45 \) and \( 30 \times 2.5 = 75 \). The therapeutic range is \( 45 \) to \( 75 \) seconds.

Worked Example 2

Target INR for atrial fibrillation is \( 2.0 \) to \( 3.0 \). An INR of \( 5.2 \) is dangerously high — the patient is at serious bleeding risk.

Worked Example 3

Enoxaparin is a low-molecular-weight heparin. Even though it is given SubQ and not monitored with aPTT, it is still a heparin product.

Common Mistakes

✕ Mixing the labs
Confusing aPTT (heparin) with PT/INR (warfarin). Match the letters.
✕ Swapping antidotes
Giving vitamin K for heparin. Vitamin K is for warfarin only.
✕ Calling it a blood thinner
Anticoagulants prevent clots; they do not dissolve existing ones.
✕ "Avoid all vitamin K"
Teach consistency, not avoidance, of green vegetables on warfarin.

Quick Reference Summary

Drug Lab Target Antidote
HeparinaPTT\( 1.5 \)–\( 2.5\times \)Protamine
WarfarinPT / INR\( 2.0 \)–\( 3.0 \)Vitamin K
DabigatranNone routine—Idarucizumab
ApixabanNone routine—Andexanet alfa

Question 1 of 5

Which lab value does the nurse monitor for a patient receiving a continuous heparin infusion?

Question 2 of 5

A patient on warfarin has an INR of \( 6.0 \). Which medication does the nurse anticipate?

Question 3 of 5

Which teaching statement by a patient on warfarin requires further education?

Question 4 of 5

A patient on a heparin drip has an aPTT of \( 95 \) seconds (control \( 30 \), range \( 45 \)–\( 75 \)). What is the priority action?

Question 5 of 5

Which finding in a patient receiving anticoagulants should the nurse report immediately?